Literature DB >> 18039141

Molecular biology and pathology of lymphangiogenesis.

Terhi Karpanen1, Kari Alitalo.   

Abstract

The lymphatic vasculature is essential for the maintenance of tissue fluid balance, immune surveillance, and adsorption fatty acids in the gut. The lymphatic vessels are also crucially involved in the pathogenesis of diseases such as tumor metastasis, lymphedema, and various inflammatory conditions. Attempts to control or treat these diseases have drawn a lot of interest to lymphatic vascular research during the past few years. Recently, several markers specific for lymphatic endothelium and models for lymphatic vascular research have been characterized, enabling great technical progress in lymphatic vascular biology, and many critical regulators of lymphatic vessel growth have been identified. Despite these significant achievements, our understanding of the lymphatic vessel development and pathogenesis is still rather limited. Several key questions remain to be resolved, including the relative contributions of different pathways targeting lymphatic vasculature, the molecular and cellular processes of lymphatic maturation, and the detailed mechanisms of tumor metastasis via the lymphatic system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18039141     DOI: 10.1146/annurev.pathmechdis.3.121806.151515

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  139 in total

1.  [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Authors:  T Martini; P Ströbel; A Steidler; N Petrakopoulou; P Erben; C Bolenz
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

Review 2.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.

Authors:  Inés Martínez-Corral; David Olmeda; Rodrigo Diéguez-Hurtado; Tuomas Tammela; Kari Alitalo; Sagrario Ortega
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 4.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 5.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

Review 6.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 7.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

8.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 9.  Endothelial Metabolic Control of Lymphangiogenesis.

Authors:  Pengchun Yu; Guosheng Wu; Heon-Woo Lee; Michael Simons
Journal:  Bioessays       Date:  2018-05-11       Impact factor: 4.345

10.  Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.

Authors:  Shintaro Nakao; Souska Zandi; Ri-ichiro Kohno; Dawei Sun; Takahito Nakama; Keijiro Ishikawa; Shigeo Yoshida; Hiroshi Enaida; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.